SNMMI's communications staff is available to handle your inquiries, arrange interviews with experts, provide copies of research articles and more.
For assistance, please contact Laurie Callahan, public relations, at firstname.lastname@example.org or (703) 652-6773.
SNMMI is dedicated to being the premier source of information on nuclear medicine and molecular imaging. SNMMI's online newsroom provides reporters with the information needed to write articles and gain background information on the many topics related to molecular imaging and therapy and nuclear medicine.
SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.
View press releases on the latest research and news from SNMMI.
Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.
SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)—which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.
Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research. JNM's Newsline offers in-depth reporting on news affecting every facet of the field—the latest scientific events, government decisions, industry developments, socio-economic trends, and a broad selection of reviews from the literature.
Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.
SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Laurie Callahan, SNMMI's acting associate director of public relations, at email@example.com or at (703) 652-6773, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.
Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.
SNMMI 2018 Annual Meeting News, Announcements, Research
June 23-26, Philadelphia, Pennsylvania
Pennsylvania Convention Center
Scientific Research - (All releases embargoed. Please check embargo dates on releases when provided in advance; contact Laurie Callahan at firstname.lastname@example.org, 703-652-6773-office, 571-294-1973-cell, if you need embargoed releases in advance)
General Clinical Specialties
Instrumentation and Data Analysis
Molecular Targeting Probes
Oncology - Basic
Oncology - Clinical
Also announced at the Annual Meeting: SNMMI Image of the Year, SNMMI/SNMMI-TS Officers, and Awards
SNMMI and other societies and organizations in the nuclear medicine community have sent joint letters to the U.S. Senate and House chairs and ranking members of the respective Subcommittees on Energy and Water Development of the Committees on Appropriations, voicing support for $67.4 million to secure a sufficient domestic supply of the medical isotope molybdenum-99 (Mo-99).
(Government Relations News)
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the first large-scale longitudinal imaging study to evaluate BACE1 inhibition with micro-PET in mouse models of Alzheimer’s disease. PET imaging has been established as an excellent identifier of the amyloid plaque and tau tangles that characterize Alzheimer’s disease. Now it is proving to be an effective way to gauge treatment effectiveness.
For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference. In a study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation treatment.
SNMMI has submitted comments to the NRC on its open petition for rulemaking, asking that its regulations be revised to include radionuclides and their corresponding activities to the list of "Quantities of Licensed Material Requiring Labeling."
(Government Relations News)
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.